| Serial Number | 86970800 |
| Word Mark | ABACCEL |
| Filing Date | Monday, April 11, 2016 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Friday, September 13, 2024 |
| Registration Number | 5283583 |
| Registration Date | Tuesday, September 12, 2017 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 27, 2017 |
| Goods and Services | Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of peptides or antibodies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, or antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and nonhuman lead antibody technology, namely scientific research and analysis in the field of antibody research and antibody optimization |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 15, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AbCheck s.r.o. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Plzen 30100 CZ |
| Party Name | AbCheck s.r.o. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Plzen 30100 CZ |
| Party Name | AbCheck s.r.o. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Plzen 30100 CZ |
| Event Date | Event Description |
| Friday, July 29, 2016 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, April 14, 2016 | NEW APPLICATION ENTERED |
| Friday, April 15, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 26, 2016 | ASSIGNED TO EXAMINER |
| Friday, July 29, 2016 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, August 3, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 3, 2016 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 3, 2016 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 1, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 16, 2017 | ASSIGNED TO LIE |
| Thursday, February 23, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 23, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 24, 2017 | FINAL REFUSAL E-MAILED |
| Friday, March 24, 2017 | FINAL REFUSAL WRITTEN |
| Friday, March 24, 2017 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, March 6, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Wednesday, April 12, 2017 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, April 12, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 13, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 4, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 7, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 27, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 27, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 12, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Monday, September 12, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, September 13, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, September 13, 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Friday, September 13, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |